Recruiting

Lung Transplant

Sponsor:

University of Washington

Code:

NCT06032273

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Investigator-designed lung transplant education website

Study Details

Brief summary:

Lung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the United States, more people with CF and low lung function die each year than undergo lung transplant. More than half of people with CF who die without a lung transplant were never referred for consideration. Patient preference not to undergo lung transplant may account for 25-40% of decisions to defer referral.

Patients' health discussion networks function to support individuals in health related matters and may provide critical support during the lung transplant journey. Increasing awareness of lung transplant, and promoting the process of deliberation and utilization of social support, could reduce the number of people with CF who die without lung transplant. Additionally, the most common patient-endorsed barrier to lung transplant discussions is a worry about being a burden on family and friends after lung transplant. For lung transplant recipients with complex post-operative courses, low social support is associated with increased mortality. Additionally, adequate social support is a requirement at all lung transplant programs in the US.

Investigators are interested in understanding how caregivers may benefit from using lung transplant educational resources and how caregivers prepare for having discussions with their loved ones and/or helping them make decisions about lung transplant as a treatment option for advanced CF. The purpose of this study is to test whether an investigator-designed research website compared to no caregiver intervention reduces caregiver burden (assessed with the Brief Assessment Scale for Caregivers, BASC), caregiver preparedness for lung transplant discussions, and caregiver lung transplant knowledge as an ancillary study in a multicenter RCT. Further, investigators will assess patient perceptions of caregiver support as measured by the Social Support Effectiveness Questionnaire (SSE-Q) and evaluate caregivers' willingness to provide support through semi-structured interviews in patient-caregiver dyads.

Study involvement will span 6 months and study activities will involve the following:

  • Three Zoom research sessions (15-90 minutes each)
  • Survey assessments and an interview
  • Access to a research website that contains educational resources about lung transplant

Conditions

Cystic Fibrosis

Study ID

NCT06032273

Start date

Sep 6, 2023

Status verified date

Dec, 2024

Completion date

Jul 31, 2027

Anticipated

Primary completion date

Sep 30, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Identified as a caregiver or loved one of an individual with CF enrolled in the Lung Transplant READY CF 2 parent RCT, or
  • An individual with CF enrolled in the Lung Transplant READY CF 2 parent RCT

Exclusion Criteria:

  • People who are unable to provide informed consent
  • Unable to read or understand English or Spanish to complete surveys or access the website (currently only available in English and Spanish)

Study Design

Enrollment

132 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Access to investigator-designed lung transplant education website

Access to an investigator-designed web-based educational resource with information about lung transplant for three months.

no intervention: No access to lung transplant education website

No access to the investigator-designed lung transplant educational resource.

Interventions

Investigator-designed lung transplant education website

Caregiver participants assigned to the intervention will access the investigator-designed educational resource via their login to a secure website.

Primary outcome measure

  • Brief Assessment Scale for Caregivers (BASC) [ Time Frame: Measured at the 3-month and 6-month study visits ]
  • Social Support Effectiveness Questionnaire (SSE-Q) [ Time Frame: Measured at the 3-month and 6-month study visits ]

Central Contacts and Locations

Central contacts

Lauren Bartlett, BS, CCRC

503-583-2869lrejman@uw.edu

Locations

University of Washington Medical Center - Montlake

Recruiting

Seattle, Washington, United States, 98195

Contacts

Lauren Bartlett, BS, CCRC

503-583-2869lrejman@uw.edu

More Information

Sponsor

University of Washington

Last update posted

Dec 6, 2024

Last verified

Dec, 2024

Keywords

  • Cystic Fibrosis
  • Lung Transplantation
  • Advanced Lung Disease
  • Caregiver

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Washington on 2024-12-06.